Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams is a time-consuming, expensive, and often decentralized process. BaseCase is “no-code” platform that enables you to visualize large complex datasets and economic models, which demonstrates the value of products to key decision-makers.
Major Release to Help Life Science Companies Maximize Go-to-Market Impact Princeton, N.J., 2021年7月8日. Certara, a global leader in biosimulation, today announced the release of BaseCase software version 2021.06, which updates the value communication software platform to include new capabilities that can provide biopharmaceutical and medical device companies greater commercial success for new therapies … Continued
This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence and Value Communications Symposium. This session featured the following four speakers: Shawn W. Bates is vice president of US sales and business development, Maximilian Vargas is senior director of US access strategy and account management, and Alex Solis is a … Continued
The days of simply determining the market demand for a new drug as a function of price and choosing the revenue or profit optimizing point are gone. In our new environment, an explicit rationale, the “value-based price” has become a prerequisite for enabling conversation with payers while policy-makers seem poised to limit the pricing corridors … Continued
The days of simply determining the market demand for a new drug as a function of price and choosing the revenue or profit optimizing point are gone. In our new environment, an explicit rationale, the “value-based price” has become a prerequisite for enabling conversation with payers while policy-makers seem poised to limit the pricing corridors … Continued
Real-World Data (RWD) have been increasingly used to further understand the natural history of a disease or condition, treatment patterns in RW practice, as well as the effectiveness, safety and costs associated with treatment options. They help exploring research questions, potentially complement clinical trial findings, and fill knowledge gaps. Different existing data sources can be … Continued
ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する... Watch this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する... In this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する... Watch this short clip by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
ヨーロッパの実世界のデータソースの中で、フランスのヘルスケアデータベースSNDSは、最大かつ最も包括的なヘルスケアデータリソースであり、フランス人口の99%以上、ヨーロッパの10％程度に相当する... Watch this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at … Continued
